Ikena Oncology Inc [IKNA] stock prices are up 7.74% to $1.67 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The IKNA shares have gain 3.73% over the last week, with a monthly amount drifted -3.47%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Ikena Oncology Inc [NASDAQ: IKNA] stock has seen the most recent analyst activity on May 29, 2024, when Wedbush downgraded its rating to a Neutral and also revised its price target to $2 from $8. Previously, Wedbush started tracking the stock with Outperform rating on September 22, 2023, and set its price target to $11. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $25 on December 23, 2021. In a note dated April 20, 2021, William Blair initiated an Outperform rating.
The stock price of Ikena Oncology Inc [IKNA] has been fluctuating between $1.22 and $2.30 over the past year. Currently, Wall Street analysts expect the stock to reach $1.33 within the next 12 months. Ikena Oncology Inc [NASDAQ: IKNA] shares were valued at $1.67 at the most recent close of the market. An investor can expect a potential drop of -20.36% based on the average IKNA price forecast.
Analyzing the IKNA fundamentals
The Ikena Oncology Inc [NASDAQ:IKNA] reported sales of 0.66M for trailing twelve months, representing a drop of -100.00%. Gross Profit Margin for this corporation currently stands at 0.07% with Operating Profit Margin at -98.78%, Pretax Profit Margin comes in at -90.53%, and Net Profit Margin reading is -90.44%. To continue investigating profitability, this company’s Return on Assets is posted at -0.4, Equity is -0.4 and Total Capital is -0.47.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.5533 points at the first support level, and at 1.4367 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.8633, and for the 2nd resistance point, it is at 2.0567.
Ratios To Look Out For
It’s worth pointing out that Ikena Oncology Inc [NASDAQ:IKNA]’s Current Ratio is 15.32. As well, the Quick Ratio is 15.32, while the Cash Ratio is 4.89. Considering the valuation of this stock, the price to sales ratio is 117.56, the price to book ratio is 0.60.
